Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 4 SUPPL. S1, 2000, Pages 29-33

  Duffy, Lynn B ^a   Crabb, Donna ^a   Searcey, Karen ^a   Kempf, Mirjam C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; GEMIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; MACROLIDE; QUINOLONE DERIVATIVE; TETRACYCLINE; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; CULTURE MEDIUM; DILUTION; DRUG POTENCY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA; MYCOPLASMA GENITALIUM; MYCOPLASMA HOMINIS; MYCOPLASMA PNEUMONIA; NONHUMAN; POWDER; RESPIRATORY TRACT INFECTION; UREAPLASMA UREALYTICUM; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CLINDAMYCIN; FLUOROQUINOLONES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA; NAPHTHYRIDINES; TETRACYCLINE;

EID: 0034076785     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cassell, G. H., Clyde, W. A. & Davis, J. K. (1985). Mycoplasmal respiratory infections. In The Mycoplasmas, Vol. IV, (Razin, S. & Barile, M. F., Eds), pp. 65-106. Academic Press, New York.
2. Chow, A. W. (1984). Erythromycin. In Antimicrobial Therapy, (Ristuccia, A. M. & Cunha, B. A., Eds), pp. 209-21. Raven Press, New York.
3. Cassell, G. H., Davis, J. K., Waites, K. B., Rudd, P. T., Talkington, D., Crouse, D. et al. (1987). Pathogenesis and significance of urogenital mycoplasmal infections. Advances in Experimental Medicine and Biology 224, 93-115.
4. Cassell, G. H., Waites, K. B. & Crouse, D. T. (1991). Perinatal mycoplasmal infections. Clinics in Perinatology 18, 241-62.
5. Cassell, G. H., Crouse, D. T., Waites, K. B., Rudd, P. T. & Davis, J. K. (1988). Does Ureaplasma urealyticum cause respiratory disease in newborns? Pediatric Infectious Disease Journal 7, 535-41.
6. Cassell, G. H., Waites, K. B., Crouse, D. T., Rudd, P. T., Canupp, K. C., Stagno, S. et al. (1988). Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birthweight infants. Lancet ii, 240-5.
7. Waites, K. B., Crouse, D. T., Philips, J. B., Canupp, K. C. & Cassell, G. H. (1989). Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn. Pediatrics 83, 79-85.
8. Waites, K. B., Rudd, P. T., Crouse, D. T., Canupp, K. C., Nelson, K. G., Ramsey, C. et al. (1988). Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet i, 17-21.
9. Taylor-Robinson, D., Furr, P. M. & Webster, A. D. B. (1986). Ureaplasma urealyticum in the immunocompromised host. Pediatric Infectious Disease 5, Suppl., S236-8.
10. Cummings, M. C. & McCormack, W. M. (1990). Increase in resistance of Mycoplasma hominis to tetracyclines. Antimicrobial Agents and Chemotherapy 34, 2297-9.
11. Evans, R. T. & Taylor-Robinson, D. (1978). The incidence of tetracycline-resistant strains of Ureaplasma urealyticum. Journal of Antimicrobial Chemotherapy 4, 57-63.
12. Roberts, M. C. & Kenny, G. E. (1986). TetM tetracycline-resistant determinants in Ureaplasma urealyticum. Pediatric Infectious Disease 5, Suppl., S338-40.
13. Taylor-Robinson, D. & Furr, P. M. (1986). Clinical antibiotic resistance of Ureaplasma urealyticum. Pediatric Infectious Disease 5, Suppl., S335-7.
14. Baseman, J. B., Dallo, S. F., Tully, J. G. & Rose, D. L. (1988). Isolation and characterization of Mycoplasma genitalium strains from the human respiratory tract. Journal of Clinical Microbiology 26, 2266-9.
15. Waites, K. B. & Cassell, G. H. (1994). Clinical applications of fluoroquinolones for genital mycoplasma infections. Infections in Medicine 11, 71-80.
16. Cassell, G. H., Blanchard, A., Duffy, L., Crabb, D. & Waites, K. B. (1994). Mycoplasmas. In Clinical and Pathogenic Microbiology, (Howard, B. J., Keiser, J. F., Weissfeld, A. S., Smith, T. F. & Tilton, R. C., Eds), pp. 491-502. Mosby Year Book, St Louis, MO.
17. Yanez, A., Cedillo, L., Neyrolles, O., Alonso, E., Prevost, M. C., Rojas, J. et al. (1999). Mycoplasma penetrans bacteraemia and primary antiphospholipid syndrome. Emerging Infectious Diseases 5, 164-7.
18. Moore, T., Niconovich, N. & Coleman, K. (1998). SB-265805 (LB20304a): in vitro antibacterial activity against the common respiratory tract pathogens Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. In Program and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract F-098, p. 257. American Society for Microbiology, Washington, DC.
19. Kim, M. Y., Paek, K. S. & Choo, Y. S. (1998). SB-265805 (LB20304a): in vitro antibacterial activity against respiratory tract pathogens. In Program and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract F-093, p. 256. American Society for Microbiology, Washington, DC.
20. Critchley, I. A., Broskey, J. & Coleman, K. (1998). SB-265805 (LB20304a): in vitro activity, intracellular accumulation and killing of Legionella pneumophila in human macrophages. In Program and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract F-100, p. 257. American Society for Microbiology, Washington, DC.
21. Dubois, J. & St Pierre, C. (1998). SB-265805 (LB20304a): an in vitro susceptibility study against Legionella spp. In Program and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract F-105, p. 258. American Society for Microbiology, Washington, DC.
22. Ridgway, G., Salman, H., Clark, S., Mathias, I. & Felmingham, D. (1998). SB-265805 (LB20304a): comparative in vitro activity against Legionella pneumophila and Chlamydia spp. In Program and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract F-097, p. 256. American Society for Microbiology, Washington, DC.
23. Hannan, P. & Woodnutt, G. (1998). SB-265805 (LB20304a): susceptibility of human mycoplasmas in vitro. In Program and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract F-101, p. 257. American Society for Microbiology, Washington, DC.
24. Bebear, C. & Robertson, J. A. (1996). Determination of minimal inhibitory concentration. In Molecular and Diagnostic Procedures in Mycoplasmology, Vol. 2, (Tully, J. G. & Razin, S., Eds), pp. 189-97. Academic Press, San Diego, CA.
25. Waites, K. B., Crouse, D. T. & Cassell, G. H. (1992). Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates. Pediatric Infectious Disease Journal 11, 23-9.